Microglia: Friends or Foes in Glaucoma? A Developmental Perspective

Area of Science:

• Neuroscience
• Ophthalmology
• Immunology

Background:

• Glaucoma is a leading cause of irreversible vision loss due to retinal ganglion cell (RGC) degeneration.
• The precise mechanisms driving RGC loss in glaucoma are not fully understood.
• Microglia, the central nervous system's immune cells, play critical roles in neural development and homeostasis.

Purpose of the Study:

• To explore the role of microglia in the development and degeneration of RGCs.
• To investigate how microglia-mediated processes might contribute to glaucoma pathogenesis.
• To identify microglia as a potential therapeutic target for glaucoma.

Main Methods:

• Review of existing literature on microglia function in neurodevelopment and neurodegeneration.
• Analysis of the interplay between microglia and RGCs in physiological and pathological conditions.
• Discussion of therapeutic strategies targeting microglia in glaucoma.

Main Results:

• Microglia are essential for RGC development and survival.
• Dysfunctional microglia may contribute to RGC loss in glaucoma.
• Aberrant reactivation of developmental microglial pathways could initiate or worsen glaucoma.

Conclusions:

• Microglia are implicated in both normal RGC development and glaucomatous degeneration.
• Understanding microglia's dual role is crucial for developing effective glaucoma therapies.
• Targeting microglia presents a promising avenue for future glaucoma treatments.